Symbiotec Pharmalab prepares for its IPO listing today. Analysts predict a potential 20-22% rise based on the latest grey market premium.
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.